Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers

Infection Control and Hospital Epidemiology

Volumn 38, Issue 8, 2017, Pages 937-944

  Jones, Barbara E ^a,b   Brown, Kevin Antoine ^a,i,j   Jones, Makoto M ^a,c   Huttner, Benedikt D ^a,d   Greene, Tom ^c   Sauer, Brian C ^a,c   Madaras Kelly, Karl ^e,f   Rubin, Michael A ^a,c   Bidwell Goetz, Matthew ^g,h   Samore, Matthew H ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e Boise VA Medical Center   (United States)

^f IDAHO STATE UNIVERSITY   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ PUBLIC HEALTH ONTARIO   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CLAVULANIC ACID; DORIPENEM; IMIPENEM; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD ANALYSIS; BLOOD CULTURE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEALTH CARE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; PREVALENCE; PSEUDOMONAS AERUGINOSA; RURAL AREA; VERY ELDERLY; BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED INFECTION; CROSS INFECTION; METHICILLIN RESISTANCE; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS INFECTION; PUBLIC HOSPITAL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HOSPITALIZATION; HOSPITALS, VETERANS; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; UNITED STATES;

EID: 85021111333     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.98     Document Type: Article

References (38)

1. National Center for Health Statistics. Fastats: Pneumonia. Centers for Disease Control and Prevention website. http://www. cdc. gov/nchs/fastats/pneumonia. htm. Updated 2017. Accessed April 21, 2017.
2. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013;310:591-608.
3. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-S72.
4. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
5. Facts about ORYX for hospitals (National Hospital Quality Measures). The Joint Commission website. http://www. joint commission. org/assets/1/6/ORYX-for-Hospitals. pdf. Updated 2017. Accessed April 21, 2017.
6. Jones BE, Jones MM, Huttner B, et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128medical centers, 2006-2010. Clin Infect Dis 2015;61:1403-1410.
7. Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis 2016;63:300-309.
8. Wunderink RG. Community-acquired pneumonia versus healthcare-associated pneumonia. The returning pendulum. Am J Respir Crit Care Med 2013;188:896-898.
9. Flanders SA, Halm EA. Guidelines for community-acquired pneumonia: Are they reflected in practice Treat Respir Med 2004; 3:67-77.
10. Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012;54:470e8.
11. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia Chest 2010;137:1283-1288.
12. Lindenauer PK, Lagu T, Shieh MS, et al. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA 2012;307:1405-1413.
13. Rhunke GW, Coca-Perraillon M, Kitch BT, Cutler DM. Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med 2011;124:171-178.
14. US Department of Veterans Affairs. VA Informatics and Computing Infrastructure (VINCI). http://hsrd. research. va. gov/ for-researchers/vinci. Accessed February 19, 2016.
15. 2012 VHA facility quality and safety report. Department of Veterans Affairs, Veterans Health Administration website. https://www. va. gov/HEALTH/docs/VHA-Quality-and-Safety- Report-2013. pdf. Published 2013. Accessed May 11, 2017.
16. Christiansen CL, Morris CN. Improving the statistical approach to health care provider profiling. Ann Intern Med 1997;127:764-768.
17. SNOMed International website. http://www. snomed. org. Accessed April 21, 2017.
18. Schneider R, Bagby J, Carlson R. Bar-code medication administration: A systems perspective. Am J Health Syst Pharm 2008; 65:2216, 8-9.
19. Austin PC. Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model. J Clin Epidemiol 2010;63:2-6.
20. Fox J. Bootstrapping regression models. Appendix to An R and S-PLUS Companion to Applied Regression website. https://socserv. socsci. mcmaster. ca/jfox/Books/Companion-1E/appendix-boot strapping. pdf. Published January 2002 and corrected January 2008). Accessed April 21, 2017.
21. Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo MI. Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulm Med 2016;22:219-226.
22. Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: A systematic review and meta-analysis. Clin Infect Dis 2014;58:330-339
23. Erratum: Clin Infect Dis 2015;60:1143.
24. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL. Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia. J Hosp Med 2012;7:195-202.
25. Metersky ML, Frei CR, Mortensen EM. Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia. Respirology 2016; 21:157-163.
26. Jones M, Ying J, Huttner B, et al. Relationships between the importation, transmission, and nosocomial infections of methicillin-resistant Staphylococcus aureus: An observational study of 112 Veterans Affairs Medical Centers. Clin Infect Dis 2014;58:32-39.
27. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds Principles and Practice of Infectious Diseases. 5th ed. New York, NY: Churchill Livingstone; 2000.
28. Thomas JC, Weber DJ. Epidemiologic Methods for the Study of Infectious Diseases. Oxford: Oxford University Press; 2001.
29. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Archives Intern Med 2008;168:2205-2210.
30. Shindo Y, Ito R, Kobayashi D, Ando M, et al. Risk factors for drugresistant pathogens in community-acquired and healthcareassociated pneumonia. Am J Respir Crit CareMed 2013;188:985-995.
31. Webb BJ, Dascomb K, Stenehjem E, et al. Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score. Antimicrob Agents Chemother 2016;60:2652-2663.
32. Kalil AC, Metersky ML, Klompas M, et al. Executive summary: management of adults with hospital-acquired and ventilatorassociated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63:575-582.
33. Waterer GW. Healthcare-associated pneumonia: can we salvage anything from the wreckage Respirology 2016;21:8-9.
34. Chalmers JD, Reyes LF, Aliberti S, Restrepo MI. Empirical coverage of MRSA in community-acquired pneumonia: Those who do not remember the past are doomed to repeat it. Clin Infect Dis 2016;63:1145-1146.
35. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: A new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867-873.
36. Swami SK, Banerjee R. Comparison of hospital-wide and age and location-stratified antibiograms of S. Aureus, E. coli, and S. pneumoniae: Age-and location-stratified antibiograms. SpringerPlus 2013;2:63.
37. Bosso JA, Sieg A, Mauldin PD. Comparison of hospitalwide and custom antibiograms for clinical isolates of Pseudomonas aeruginosa. Hosp Pharmacy 2013;48:295-301.
38. Jones M, Huttner B, Leecaster M, et al. Does universal active MRSA surveillance influence anti-MRSA antibiotic use A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010. J Antimicrob Chemother 2014;69:3401-3408.